Abstract:Abstract The Oncotype DX (ODX) is a 21 panel gene-expression based assay for identifying which Estrogen Receptor-positive (ER+) breast cancer (BCa) patients are candidates for adjuvant chemotherapy. The objective of this research was to identify whether computerized texture features on a staging DCE-MRI can distinguish ER+ BCa with low and high ODX recurrence scores (RS) (i.e. to distinguish which ER+ BCa patients are more likely to benefit from adjuvant hormonal therapy from those who require chemotherapy). This would provide a non-invasive, imaging based, pre-therapeutic assessment tool for predicting the appropriate treatment regimen. This work, to the best of our knowledge, is the first attempt to quantitatively correlate low versus high risk stratification via computer derived MRI measurements to corresponding risk stratification via the ODX assay. 52 ER+ BCa patient studies with high (>30, N = 28) and low (<18, N = 24) ODX RS were available for this study from two sites; 16 breast MRIs from the Boston Medical Center using a Phillips 1.5T magnet with a 7-channel breast coil, and 36 MRIs from the Case Medical Center using a Siemens 1.5T magnet with a 8-channel breast coil. All datasets included T1w images obtained prior to, during, and after administration of 0.1 mmol/kg of Gd-DTPA and corresponding ODX RS. For each study a radiologist picked a representative slice showing the tumor and then manually segmented the region of interest (ROI) containing the lesion. Computerized image analysis tools developed in-house via the MATLAB© programming platform were applied to the manually segmented lesion ROI for each of the 52 MRI studies to quantitatively characterize the lesion via a set of (a) 6 shape, (b) 3 pharmacokinetic (Ktrans, ve, kep) based on Tofts model (PK), (c) 12 enhancement kinetic (EK), (d) 12 intensity kinetic (IK), (e) 312 textural kinetic (TK), (f) 6 dynamic local binary pattern (DLBP), and (g) 5 dynamic histogram of oriented gradient (DHoG) features. The computer extracted features were evaluated via a linear discriminant analysis (LDA) classifier in terms of their ability to distinguish ER+ BCa as having a low or high ODX RS via a 2-fold randomized cross validation scheme. At each iteration, half of the studies were randomly selected from the 52 cases and used for training the LDA classifier and the remaining 26 studies were used for independent testing. This process was repeated 200 times. Classification performance was evaluated by area under the ROC curve (AUC). Higher AUC values suggest a stronger relationship between risk stratification via MRI attributes and ODX. Table 1Feature classAccuracy (μ±Δ)AUC (μ±Δ)DHoG87.07%±5.66%0.89±0.04DLBP85.86%±7.82%0.83±0.07EK82.36%±8.46%0.80±0.06PK81.14%±7.55%0.78±0.07TK75.93%±6.65%0.76±0.08IK76.43%±7.23%0.75±0.12Shape71.04%±6.81%0.70±0.06 Table 1 illustrates the mean and standard deviation in accuracy and AUC values over 200 runs of randomized cross validation. DHoG, DBLP and EK features yielded the highest classification accuracy and AUC. Although lesion shape has been shown to be important for discriminating benign and malignant lesions on MRI, shape appears to be less useful in distinguishing between ER+ BCa lesions with low and high ODX RS. Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr P2-02-12.

Dynamic Contrast-Enhanced MRI in Orbital Lymphoproliferative Disorders: Effects of Region of Interest Selection Methods on Time Efficiency, Measurement Reproducibility, and Diagnostic Ability.

Orbital Benign and Malignant Lymphoproliferative Disorders: Differentiation Using Semi-Quantitative and Quantitative Analysis of Dynamic Contrast-Enhanced Magnetic Resonance Imaging.

Histogram Analysis of Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Differentiating Malignant from Benign Orbital Lymphproliferative Disorders

Benign and Malignant Orbital Lymphoproliferative Disorders: Differentiating Using Multiparametric MRI at 3.0T

Differential diagnosis of nasopharyngeal carcinoma and nasopharyngeal lymphoma based on DCE-MRI and RESOLVE-DWI

Assessment of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in the Differentiation of Malignant from Benign Orbital Masses

Combined Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced MRI for Differentiating Radiologically Indeterminate Malignant from Benign Orbital Masses

Diffusion Weighted Imaging for Differentiating Benign from Malignant Orbital Tumors: Diagnostic Performance of the Apparent Diffusion Coefficient Based on Region of Interest Selection Method

Quantitative dynamic contrast-enhanced MR imaging for differentiating benign, borderline, and malignant ovarian tumors

Diagnostic Performance of Dynamic Contrast-Enhanced 3T MR Imaging for Characterization of Orbital Lesions: Validation in a Large Prospective Study

Differentiation Between Orbital Malignant and Benign Tumors Using Intravoxel Incoherent Motion Diffusion-Weighted Imaging

The value of dynamic contrast-enhanced MRI in estimating adjacent bones’ and extraocular muscles’ involvement of orbital malignant neoplasm

Dynamic Contrast-Enhanced Magnetic Resonance Imaging of Ocular Melanoma as a Tool to Predict Metastatic Potential.

Differentiation of Orbital Lymphoma and Idiopathic Orbital Inflammatory Pseudotumor: Combined Diagnostic Value of Conventional MRI and Histogram Analysis of ADC Maps

Differentiation of Malignant from Benign Orbital Tumours Using Dual-Energy CT.

Abstract P2-02-12: Computer Derived Image Features on DCE-MRI Appear to Distinguish Estrogen Receptor-Positive Breast Cancers with Low and High Oncotype DX Recurrence Scores

Diagnostic Value of Dynamic Contrast Enhancement Combined with Conventional MRI in Differentiating Benign and Malignant Lacrimal Gland Epithelial Tumours.

To Explore MR Imaging Radiomics for the Differentiation of Orbital Lymphoma and IgG4-Related Ophthalmic Disease

Evaluation of orbital lesions with DCE-MRI: a literature review

Comparison of Intravoxel Incoherent Motion Diffusion-Weighted Mr Imaging with Dynamic Contrast-Enhanced Mri for Differentiating Lung Cancer from Benign Solitary Pulmonary Lesions

Bag-of-features-based Radiomics for Differentiation of Ocular Adnexal Lymphoma and Idiopathic Orbital Inflammation from Contrast-Enhanced MRI